← Eichor
Condition: Donafenib Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Donafenib

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC
NA · 1 location(s) · Sun Yat-sen University · NCT06609876Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
NA · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06581315TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
Phase 2 · 1 location(s) · Fei Gao · NCT06646198Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recur
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06685289HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectabl
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06244225HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients
Phase 2 · 3 location(s) · Fudan University · NCT06812039Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
Phase 2 · 1 location(s) · Yu Wang · NCT06787911Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With E
Phase 2 · 2 location(s) · Anhui Provincial Hospital · NCT06498622GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma
Phase 2 · 1 location(s) · Fudan University · NCT05668884
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.